Background: A consensus protocol for genetic counselling and testing of familial dementia, the Italian Dominantly Inherited Alzheimer’s and Frontotemporal Network (IT-DIAfN) protocol, has been developed in Italy by a network of expert dementia centres. The aim of this study is to evaluate feasibility and acceptability of the genetic counselling and testing process, as undertaken according to the IT-DIAfN protocol in one of the IT-DIAfN dementia research centres. Methods: The protocol was tested by a multidisciplinary team at the IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy, on affected individuals with suspected inherited forms of Alzheimer’s disease (AD) or frontotemporal dementia (FTD), and to healthy at-risk...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical manifestations of dementia are often rapidly matched to a specific clinical syndrome, b...
Dementing disorders are a complex group of neurodegenerative diseases characterised by different, bu...
Background: Genetic testing of familial Alzheimer's disease (AD) and frontotemporal lobar degenerati...
Background: Genetic testing of familial Alzheimer's disease (AD) and frontotemporal lobar degenerati...
Genetic testing of familial Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD) is...
Techniques for clinical genetic testing in dementia disorders have advanced rapidly but remain to be...
OBJECTIVE: When a genetic cause is suspected in a person with dementia, it creates unique diagnostic...
25% of all people aged 55 years and older have a family history of dementia. For most, the family hi...
Introduction: We describe the 5 year experience of a genetic counselling program for familial dement...
INTRODUCTION: Motor neuron disease (MND) and frontotemporal dementia (FTD) comprise a neurodegenerat...
OBJECTIVE: Purposes of this study are: (1) to evaluate attitudes, beliefs and experiences towards de...
A decade of genetic counseling of frontotemporal dementia (FTD) affected families has generated two ...
Hereditary transthyretin amyloidosis (ATTRv, v for variant) is a late-onset, autosomal dominant dise...
A decade of genetic counseling of frontotemporal dementia (FTD) affected families has generated two ...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical manifestations of dementia are often rapidly matched to a specific clinical syndrome, b...
Dementing disorders are a complex group of neurodegenerative diseases characterised by different, bu...
Background: Genetic testing of familial Alzheimer's disease (AD) and frontotemporal lobar degenerati...
Background: Genetic testing of familial Alzheimer's disease (AD) and frontotemporal lobar degenerati...
Genetic testing of familial Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD) is...
Techniques for clinical genetic testing in dementia disorders have advanced rapidly but remain to be...
OBJECTIVE: When a genetic cause is suspected in a person with dementia, it creates unique diagnostic...
25% of all people aged 55 years and older have a family history of dementia. For most, the family hi...
Introduction: We describe the 5 year experience of a genetic counselling program for familial dement...
INTRODUCTION: Motor neuron disease (MND) and frontotemporal dementia (FTD) comprise a neurodegenerat...
OBJECTIVE: Purposes of this study are: (1) to evaluate attitudes, beliefs and experiences towards de...
A decade of genetic counseling of frontotemporal dementia (FTD) affected families has generated two ...
Hereditary transthyretin amyloidosis (ATTRv, v for variant) is a late-onset, autosomal dominant dise...
A decade of genetic counseling of frontotemporal dementia (FTD) affected families has generated two ...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical manifestations of dementia are often rapidly matched to a specific clinical syndrome, b...
Dementing disorders are a complex group of neurodegenerative diseases characterised by different, bu...